Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05335889 · ClinicalTrials.gov registry record
Wearable Sensors and Artificial Intelligence for Carbohydrate Counting
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 12
- Enrollment target
NCT05335889: Completed study, sponsored by NYU Langone Health.
NCT05335889 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05335889 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This is a one-group pilot study where Chinese immigrants who are English speaking with T2D from NYU Langone Health and NYU Brooklyn Family Health Center (Sunset Park) will be recruited.
Primary Outcome
The estimated carb grams using the eButton, gold standard, and participants' food diaries will be compared head to head among each other. The absolute error will be computed: the difference between the estimated value and the gold standard (estimated - gold standard). Bland-Altman plots will be used to examine the level of agreement between eButton and gold standard measurements.
Interventions
- DEVICE Continuous Glucose Monitoring (CGM)
- DEVICE eButton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2023-09-22 |
What the finished NCT05335889 record still lists
NCT05335889 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitoring (CGM) is the first listed.
NCT05335889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05335889 about?
NCT05335889 is a clinical study titled "Wearable Sensors and Artificial Intelligence for Carbohydrate Counting". This is a one-group pilot study where Chinese immigrants who are English speaking with T2D from NYU Langone Health and NYU Brooklyn Family Health Center (Sunset Park) will be recruited.
What is the current status of trial NCT05335889?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2022-07-18. Estimated completion is 2023-09-22.
What interventions are being tested in trial NCT05335889?
The interventions under investigation include: Continuous Glucose Monitoring (CGM) (DEVICE), eButton (DEVICE).
Who is sponsoring clinical trial NCT05335889?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI